Inflammation and Cellular Immunity in Vaginal Tissue in Patients With Pelvic Organ Prolapse

NCT03748693 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2018-11-21

No results posted yet for this study

Summary

The aim of this study is to investigate the inflammatory and maturation processes of immature myeloid cells (IMC) in the vaginal tissue in women with advanced pelvic organ prolapse (POP) (stage III-IV) and in normal non-POP controls.

We hypothesize that the processes contributing to POP may be related to immune response and changes in myeloid cell populations and the cytokine environment.

Conditions

  • Pelvic Organ Prolapse

Interventions

PROCEDURE

Hysterectomy

Surgery performed on women with a variety of gynecological indications

PROCEDURE

Colporrhaphy

Surgery performed on women with POP

Sponsors & Collaborators

  • Hillel Yaffe Medical Center

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-31
Primary Completion
2019-09-30
Completion
2019-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03748693 on ClinicalTrials.gov